Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LY 355703

Drug Profile

LY 355703

Alternative Names: C-52; cryptophycin 52; Multi-drug resistance inhibitor cryptophycin 52

Latest Information Update: 27 Mar 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eli Lilly
  • Class Antineoplastics; Depsipeptides; Lactams; Lactones
  • Mechanism of Action Microtubule protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Non-small cell lung cancer; Solid tumours

Most Recent Events

  • 25 Mar 2003 A study has been added to the adverse events and Cancer therapeutic trials sections
  • 12 Aug 2002 A phase II study in non-small cell lung cancer has been added to the Cancer therapeutic trials and adverse events sections
  • 02 Nov 2001 Phase-II clinical trials in Non-small cell lung cancer in Germany (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top